Sign In  |  Register  |  About Daly City  |  Contact Us

Daly City, CA
September 01, 2020 1:20pm
7-Day Forecast | Traffic

  • Search Hotels in Daly City

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Dexcom Inc (NQ: DXCM )

77.83 +5.00 (+6.87%)
Streaming Delayed Price Updated: 4:00 PM EST, Nov 25, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Dexcom Inc

< Previous 1 2
...
12 13 14 15 16 17 18 19 20
...
31 32 Next >
Why DexCom (DXCM) Stock Hit A New 52-Week Low Today
DexCom, Inc. (NASDAQ: DXCM) shares are trading lower by 1.58% to $77.73 Thursday afternoon. 
Via Benzinga
A Bull Market Is Coming: 2 Magnificent Stock-Split Growth Stocks That Could Soar 40% and 51%, According to Wall Street
Two investor-favorite stock-split stocks still have plenty of room to run. 
Via The Motley Fool
1 Stock-Split Stock to Buy Hand Over Fist in October and 1 to Avoid
Among Nvidia, Amazon, DexCom, Shopify, Alphabet, Tesla, Palo Alto Networks, Monster Beverage, and Novo Nordisk, there's one historically cheap stock-split stock, as well as another company that carries... 
Via The Motley Fool
Here's How Much You Would Have Made Owning DexCom Stock In The Last 15 Years
Via Benzinga
Dexcom Solidifies Global Leadership in Continuous Glucose Monitoring With New Clinical Data Presented at EASD
From DexCom, Inc.
Via Business Wire
(DXCM) - Analyzing DexCom's Short Interest
Via Benzinga
Analyst Expectations for DexCom's Future
Via Benzinga
Buy this Tech Stock on the Dip in October for 50% Upside?
DexCom, Inc. is a connected medical device standout that has posted steadily massive YoY growth as more people in the U.S. and globally suffer from diabetes. 
Via Talk Markets
Dexcom Schedules Third Quarter 2023 Earnings Release and Conference Call for October 26, 2023 at 4:30 p.m. Eastern Time.
From DexCom, Inc.
Via Business Wire
Why Abbott Says It Won't Be A Casualty Of The Weight-Loss Battle
Abbott and Dexcom stocks have tumbled as GLP-1 drugs have gripped the nation. 
Via Investor's Business Daily
This Is What Whales Are Betting On DexCom
Via Benzinga
Which High-Profile Stock-Split Stock Is the Cheapest? Get Ready to Be Shocked...
Among Nvidia, Amazon, DexCom, Shopify, Alphabet, Tesla, Palo Alto Networks, Monster Beverage, and Novo Nordisk, there's one clear-cut stock-split stock that's notably cheaper than the rest. 
Via The Motley Fool
DexCom Unusual Options Activity For September 22
Via Benzinga
2 Healthcare Stocks That Could Make You Richer
They've beaten the market before. 
Via The Motley Fool
Navigating The S&P 500 Landscape: Here Are The Stocks Analysts Believe Have The Highest Potential And Biggest Downside
In the middle of the AI revolution and the Federal Reserve's steadfast stance on interest rates, the stock market has seen unexpected twists and turns. Despite hopes of the U.S. 
Via Benzinga
Topics Artificial Intelligence Stocks
Exposures Artificial Intelligence US Equities
3 Healthcare Stocks That Should Be on Every Investor’s Radar This Fall
The beauty of healthcare stocks is that they tend to do well in most economic conditions because you can’t live without them. 
Via InvestorPlace
3 Unstoppable Nasdaq 100 Stocks Just Waiting to Be Bought
Tech stocks were the primary fuel for a decades-long bull market, and these three Nasdaq stocks to buy can lead the market forward. 
Via InvestorPlace
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
DexCom Unusual Options Activity
Via Benzinga
DexCom Unusual Options Activity
Via Benzinga
$100 Invested In This Stock 15 Years Ago Would Be Worth $6,500 Today
Via Benzinga
How Is The Market Feeling About DexCom?
Via Benzinga
3 Healthcare Stocks That Turned $100,000 Into $1 Million in 10 Years
Are these highly successful stocks still good buys today? 
Via The Motley Fool
Dexcom U Kicks off 2023 Season With Expanded Roster of Athletes With Diabetes, Building on First-of-its-Kind NIL Program
From Dexcom, Inc.
Via Business Wire
3 Stock-Split Stocks Billionaire Investors Can't Stop Buying
Among Nvidia, Amazon, DexCom, Shopify, Alphabet, Tesla, Palo Alto Networks, Monster Beverage, and Novo Nordisk, there are three highfliers Wall Street's top managers are piling into. 
Via The Motley Fool
Why DexCom Stock Dove by 5% Today
A note from an increasingly cautious pundit may have created a downdraft for this high-flying glucose monitor company. 
Via The Motley Fool
Apple Taps Seasoned Executive To Head 'Secret' Team Developing Glucose Monitoring Device - Stocks To Watch
Apple Inc (NASDAQ: AAPL) has appointed Tim Millet, a seasoned executive with a background in iPhone and Mac chip technology, to oversee its secretive team dedicated to developing a noninvasive blood... 
Via Benzinga
Wall Street Has Found Its Next High-Flying Stock-Split Stock. Here's Why I'm Not Buying the Hype.
Nvidia, Amazon, DexCom, Shopify, Alphabet, Tesla, Palo Alto Networks, and Monster Beverage have all split their shares since July 2021. Next week, another industry leader will join this exclusive... 
Via The Motley Fool
Dexcom Says It Won't Be The Biggest Loser In The Weight-Loss Battle — And Shares Soar
Dexcom says the popularity of GLP-1 drugs won't hurt its continuous glucose monitors. 
Via Investor's Business Daily
AeroVironment, Daktronics, GitLab And Other Big Stocks Moving Higher On Wednesday
U.S. stocks traded lower, with the Dow Jones falling around 100 points on Wednesday. Here are some big stocks recording gains in today’s session. 
Via Benzinga
Topics Stocks
Exposures US Equities
< Previous 1 2
...
12 13 14 15 16 17 18 19 20
...
31 32 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Copyright © 2010-2020 DalyCity.com & California Media Partners, LLC. All rights reserved.